Patent US2530081A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4250041A Expired / Lapsed US ⏱️ 0.0 years remaining

Removal of heparin from blood plasma samples using an insoluble protamine reaction product

Assignee: Warner Lambert Co LLC
•
Filing: 1979-06-25
•
Granted: 1981-02-10
•
Expires: 1999-06-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention relates to a method for the removal of heparin from heparin-containing plasma test samples using an insoluble protamine reaction product, without adversely affecting subsequent testing of the plasma for clotting time. Protamine sulfate or a combination of protamine sulfate and serum albumin is cross-linked with glutaraldehyde to form an insoluble reaction product which is capable of adsorbing heparin. According to the method of this invention, excess amounts of either of the cross-linked protamine reaction products are added to blood plasma samples containing heparin and the mixture is agitated for a time sufficient to permit adsorption of substantially all heparin present. The insoluble protamine heparin complex formed is removed from the plasma along with any excess insoluble protamine reaction product. Aliquots of the heparin-free plasma may be subjected to coagulation tests in order to determine true clotting time.

Inventors

  • 👤 Arthur L. Babson
  • 👤 James E. Turner

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:18
CPC Classifications
C; C08; C08B; C08B37/00; C08B37/006; C08B37/0063; C08B37/0075; A; A61; A61K; A61K35/00; A61K35/12; A61K35/14; A61K35/16; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/107497

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 183 words
A method for removing substantially all heparin from a heparin-containing blood plasma test sample which comprises: A. Adding from about 10 to about 20 mg. of the insoluble protamine/glutaraldehyde reaction product prepared by incubating an aqueous solution containing: I. From about 1.5 to about 2.5 grams of protamine sulfate; II. From about 20 to about 30 milliliters of water; III. From about 20 to about 30 milliliters of phosphate buffer; and IV. From about 6 to about 9 milliliters of a 10% solution of glutaraldehyde in phosphate buffer; at a pH of from about 6 to about 12 and a temperature of from about 4° C. to about 10° C. overnight; per milliliter of plasma to the plasma sample; B. Agitating (A) until substantially all the heparin present in the plasma sample is adsorbed by and complexed with the insoluble protamine/glutaraldehyde reaction product; C. Allowing (B) to stand for a time sufficient to allow precipitation of the free and complexed insoluble protamine/glutaraldehyde reaction product; D. Removing the precipitate of (C) from the plasma sample to obtain substantially heparin-free plasma suitable for coagulation testing.
Claim 2
Independent Claim 183 words
A method for removing substantially all heparin from a heparin-containing blood plasma test sample which comprises: A. Adding from about 10 to about 20 mg. of the insoluble protamine/glutaraldehyde reaction product prepared by incubating an aqueous solution containing: I. From about 1.5 to about 2.5 grams of protamine sulfate; II. From about 20 to about 30 milliliters of water; III. From about 20 to about 30 milliliters of phosphate buffer; and IV. From about 6 to about 9 milliliters of a 10% solution of glutaraldehyde in phosphate buffer; at a pH of from about 6 to about 12 and a temperature of from about 4° C. to about 10° C. overnight; per milliliter of plasma to the plasma sample; B. Agitating (A) until substantially all the heparin present in the plasma sample is adsorbed by and complexed with the insoluble protamine/glutaraldehyde reaction product; C. Allowing (B) to stand for a time sufficient to allow precipitation of the free and complexed insoluble protamine/glutaraldehyde reaction product; D. Removing the precipitate of (C) from the plasma sample to obtain substantially heparin-free plasma suitable for coagulation testing.
Claim 3
Dependent Claim 20 words
A method according to claim 1 wherein, in Step A, about 14 mg. of insoluble protamine/glutaraldehyde reaction product are added.
Claim 4
Dependent Claim 22 words
A method according to claim 2 wherein, in Step B, the agitation is conducted for from about 10 to about 20 minutes.
Claim 5
Dependent Claim 24 words
A method according to claim 3 wherein, in Step C, the plasma is allowed to stand for from about 2 to about 8 minutes.
Claim 6
Independent Claim 185 words
A method for removing substantially all heparin from a heparin-containing blood plasma test sample which comprises: A. Adding from about 4 to about 14 mg. of the insoluble protamine/serum albumin/glutaraldehyde reaction product, prepared by incubating an aqueous solution containing: I. From about 0.07 to about 0.13 grams of serum albumin; II. From about 0.7 to about 1.3 grams of protamine sulfate; III. From about 20 to about 30 milliliters of water; and IV. From about 3 to about 7 milliliters of a 10% aqueous glutaraldehyde solution; at a pH of from about 6 to about 12 and a temperature of from about 4° C. to about 10° C. overnight; per milliliter of plasma to the plasma sample; B. Agitating (A) until substantially all the heparin present in the plasma sample is adsorbed by and complexed with the insoluble protamine/serum albumin/glutaraldehyde reaction product; C. Allowing (B) to stand for a time sufficient to allow precipitation of the free and complexed insoluble protamine/serum albumin/glutaraldehyde reaction product; and D. Removing the precipitate of (C) from the plasma sample to obtain a substantially heparin-free plasma suitable for coagulation testing.
Claim 7
Independent Claim 185 words
A method for removing substantially all heparin from a heparin-containing blood plasma test sample which comprises: A. Adding from about 4 to about 14 mg. of the insoluble protamine/serum albumin/glutaraldehyde reaction product, prepared by incubating an aqueous solution containing: I. From about 0.07 to about 0.13 grams of serum albumin; II. From about 0.7 to about 1.3 grams of protamine sulfate; III. From about 20 to about 30 milliliters of water; and IV. From about 3 to about 7 milliliters of a 10% aqueous glutaraldehyde solution; at a pH of from about 6 to about 12 and a temperature of from about 4° C. to about 10° C. overnight; per milliliter of plasma to the plasma sample; B. Agitating (A) until substantially all the heparin present in the plasma sample is adsorbed by and complexed with the insoluble protamine/serum albumin/glutaraldehyde reaction product; C. Allowing (B) to stand for a time sufficient to allow precipitation of the free and complexed insoluble protamine/serum albumin/glutaraldehyde reaction product; and D. Removing the precipitate of (C) from the plasma sample to obtain a substantially heparin-free plasma suitable for coagulation testing.
Claim 8
Dependent Claim 20 words
A method according to claim 5 wherein, in Step A, about 6.7 mg. of insoluble protamine/albumin/glutaraldehyde reaction product is added.
Claim 9
Dependent Claim 22 words
A method according to claim 6 wherein, in Step B, the agitation is conducted for from about 10 to about 20 minutes.
Claim 10
Dependent Claim 24 words
A method according to claim 7 wherein, in Step C, the plasma is allowed to stand for from about 2 to about 8 minutes.

References Cited (Backward Citations)

US4175182A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-02-10 1984-08-11 1985-02-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-02-10 1988-08-11 1989-02-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-02-10 1992-08-11 1993-02-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag